Etchebehere Mauricio, Lin Patrick P, Bird Justin E, Satcher Robert L, Moon Bryan S, Yu Jun, Li Liang, Lewis Valerae O
Department of Orthopaedics and Traumatology, Faculty of Medical Sciences, State University of Campinas, Campinas, São Paulo, Brazil.
Departments of Orthopaedic Oncology (P.P.L., J.E.B., R.L.S., B.S.M., and V.O.L.) and Biostatistics (J.Y. and L.L.), The University of Texas MD Anderson Cancer Center, Houston, Texas.
J Bone Joint Surg Am. 2016 Apr 6;98(7):544-51. doi: 10.2106/JBJS.O.00633.
Patellar resurfacing after routine arthroplasty remains controversial. Few studies have specifically examined the effect of patellar resurfacing on outcomes after resection of the distal part of the femur and reconstruction with a megaprosthesis. Our objective was to compare the outcomes of megaprosthesis reconstructions of the distal part of the femur with and without patellar resurfacing after resection of a distal femoral tumor.
We retrospectively reviewed the clinical records of patients with a femoral tumor who underwent resection of the distal part of the femur and endoprosthetic reconstruction between 1993 and 2013. We excluded patients who had had extra-articular knee resection, patellectomy, revision, reconstruction with an expandable prosthesis, or a proximal tibial replacement associated with the distal femoral replacement. We compared demographic characteristics, surgical variables, anterior knee pain, range of motion, extensor lag, Insall-Salvati ratio, Insall-Salvati patellar tendon insertion ratio, impingement, patellar degenerative disease, additional patellar procedures, complications, and Musculoskeletal Tumor Society (MSTS) score between the patellar resurfacing and nonresurfacing groups.
One hundred and eight patients--sixty without patellar resurfacing and forty-eight with patellar resurfacing--were included in the study. The mean age was 33.9 years (range, twelve to seventy-five years). There were fifty-four men and fifty-four women. The mean duration of follow-up was 4.5 years (range, 0.7 to twenty years). There was no significant difference in anterior knee pain between the groups (p = 0.51). Anterior knee pain did not significantly affect the range of motion, extensor lag, or reoperation or complication rate. Patellar degenerative disease occurred in 48% of the nonresurfaced knees but was not associated with focal pain. Complication rates were similar in the two groups, although peripatellar calcifications were significantly more common in the resurfacing group (19% versus 2%; p = 0.005). There was no significant difference in the mean MSTS score between the nonresurfacing (81%) and resurfacing (71%) groups (p = 0.34).
There were no differences in anterior knee pain, range of motion, extensor lag, or MSTS score between the patients with and those without patellar resurfacing. There were no cases of patellar component loosening or revision. In light of the similar outcomes in the two groups, the decision to resurface should be left up to the individual surgeon, who should take into account preoperative peripatellar pain and the status of the patella at the time of resection.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
常规关节置换术后是否进行髌骨表面置换仍存在争议。很少有研究专门探讨髌骨表面置换对股骨远端切除并使用大型假体重建后疗效的影响。我们的目的是比较股骨远端肿瘤切除后,股骨远端大型假体重建时有无髌骨表面置换的疗效。
我们回顾性分析了1993年至2013年间接受股骨远端切除及人工关节置换的股骨肿瘤患者的临床记录。排除了接受过关节外膝关节切除、髌骨切除术、翻修手术、可膨胀假体重建或与股骨远端置换相关的胫骨近端置换的患者。我们比较了髌骨表面置换组和未进行髌骨表面置换组的人口统计学特征、手术变量、膝关节前方疼痛、活动范围、伸膝滞后、Insall-Salvati比率、Insall-Salvati髌骨肌腱附着比率、撞击、髌骨退行性疾病、额外的髌骨手术、并发症以及肌肉骨骼肿瘤学会(MSTS)评分。
108例患者纳入研究,其中60例未进行髌骨表面置换,48例进行了髌骨表面置换。平均年龄为33.9岁(范围12至75岁)。男性54例,女性54例。平均随访时间为4.5年(范围0.7至20年)。两组间膝关节前方疼痛无显著差异(p = 0.51)。膝关节前方疼痛对活动范围、伸膝滞后或再次手术及并发症发生率无显著影响。48%未进行髌骨表面置换的膝关节出现髌骨退行性疾病,但与局部疼痛无关。两组并发症发生率相似,尽管髌骨周围钙化在表面置换组更常见(19%对2%;p = 0.005)。未进行髌骨表面置换组(81%)和进行髌骨表面置换组(71%)的平均MSTS评分无显著差异(p = 0.34)。
进行髌骨表面置换和未进行髌骨表面置换的患者在膝关节前方疼痛、活动范围、伸膝滞后或MSTS评分方面无差异。未出现髌骨假体松动或翻修病例。鉴于两组疗效相似,是否进行髌骨表面置换应由手术医生根据术前髌骨周围疼痛情况及切除时髌骨的状态自行决定。
治疗性III级。见作者指南中关于证据水平的完整描述。